{"SPADE_UN_09568": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2003/0144184 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2003_0144184_A1", "Patent Type": "Patent Application", "Publication Date": "2003-7-31", "Family Info": "EP1513544A2,EP1513544A4,EP1513544B1,US6713078,WO2004033479A2,WO2004033479A3", "Patent Title": "Retrocyclins: antiviral and antimicrobial peptides.", "Abstract": "Retrocyclin peptides are small antimicrobial agents with potent activity against bacteria and viruses. The peptides are nonhemolytic, and exhibit minimal in vitro cytotoxicity. A pharmaceutical composition comprising retrocyclin as an active agent is administered therapeutically to a patient suffering from a bacterial and/or viral infection, or to an individual facing exposure to a bacterial and/or viral infection, especially one caused by the HIV-1 retrovirus or other sexually-transmitted pathogens."}, {"Patent No": "US 2009/0264344 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2009_0264344_A1", "Patent Type": "Patent Application", "Publication Date": "2009-10-22", "Family Info": "US7314858,US7718610,US20050272645,WO2006052637A1", "Patent Title": "Retrocyclins, antiviral and antimicrobial peptides.", "Abstract": "Retrocyclin peptides are small antimicrobial agents with potent activity against bacteria and viruses. The peptides are nonhemolytic, and exhibit minimal in vitro cytotoxicity. A pharmaceutical composition comprising retrocyclin as an active agent is administered therapeutically to a patient suffering from a bacterial and/or viral infection, or to an individual facing exposure to a bacterial and/or viral infection, especially one caused by the HIV-1 retrovirus or other sexually-transmitted pathogens."}, {"Patent No": "US 2009/0264344 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2009_0264344_A1", "Patent Type": "Patent Application", "Publication Date": "2009-10-22", "Family Info": "US7314858,US7718610,US20050272645,WO2006052637A1", "Patent Title": "Retrocyclins, antiviral and antimicrobial peptides.", "Abstract": "Retrocyclin peptides are small antimicrobial agents with potent activity against bacteria and viruses. The peptides are nonhemolytic, and exhibit minimal in vitro cytotoxicity. A pharmaceutical composition comprising retrocyclin as an active agent is administered therapeutically to a patient suffering from a bacterial and/or viral infection, or to an individual facing exposure to a bacterial and/or viral infection, especially one caused by the HIV-1 retrovirus or other sexually-transmitted pathogens."}], "Sequence Information": {"SPADE ID": "SPADE_UN_09568", "Sequence": "RCLCRRRVC", "Sequence Length": 9, "Peptide Name": "Sequence 82 from Patent US 20030144184", "Source": "Synthetic construct", "Biological Activity": ["Antimicrobial", "Antibacterial", "Antiviral"], "Frequent Amino Acids": "RCL", "Absent Amino Acids": "ADEFGHIKMNOPQSTUWY", "Basic Residues": 4, "Acidic Residues": 0, "Hydrophobic Residues": 2, "Polar Residues": 8, "Positive Residues": 4, "Negative Residues": 0, "Mass": 1164.48, "PI": 10.44, "Net Charge": 4, "Hydrophobicity": -0.28, "Similar Sequences": [{"SPADE_ID": "SPADE_N_07920", "Similarity": 1.0, "Sequence": "MARSICFFAVAILALMLFAAYETEAGTCKAECPTWEGICINKAPCVKCCKAQPEKFTDGHCSKILRRCLC"}, {"SPADE_ID": "SPADE_N_03688", "Similarity": 1.0, "Sequence": "VTCMSYGGSCQRSCNGSFRLGGHCGHPKIRCCRR"}, {"SPADE_ID": "SPADE_N_10932", "Similarity": 1.0, "Sequence": "RRR"}]}}}